ANPCF - ANGLE achieves breakthrough with EU patent for CellKeep technology with the US to follow
(NewsDirect)
ANGLE PLC chief executive Andrew Newlanddiscussed significant advancements in the company's technology,including a European patent for the CellKeep slide, with USintellectual property protection from the US set to follow soon.
Newland told Proactive's StephenGunnion that CellKeep significantly improves the deposition of cancercells on microscope slides, a common issue in medical laboratories.This method notably reduces cell loss during the transfer process byover 70%, addressing a longstanding problem in the industry. Theinnovation involves a special funnel attached to the slide, allowinggentle centrifugation and liquid removal while maintaining cellintegrity, thereby increasing the effectiveness of subsequentanalyses.
Additionally, Newlandhighlighted the development of optimized antibodies for cellphenotyping, which are integrated into ANGLE's Parsortix system.This integration is packaged as the Portrait Plus CTC Staining Kit,simplifying the process for less experienced labs and extending marketreach. The kit includes a mix of dehydrated antibodies, designed forease of use and long shelf life, enhancing the diagnosticprocess's reliability and efficiency.
Commercially, ANGLE has introduced these innovations in acomprehensive kit format, priced at £3,000 for ten samples,significantly enhancing the company’s value offering.
Newlandalso touched on ANGLE’s positive business trajectory, mentioning abreakthrough in DNA profiling and a substantial contract with a majorpharmaceutical company, which could potentially yield significantrevenues through the development of companion diagnostics.
Contact Details
Proactive UK Ltd
+44 207989 0813
Copyright (c) 2024 TheNewswire - All rights reserved.